SFCM
ENTX icon

Seven Fleet Capital Management’s Entera Bio ENTX Stock Holding History

Seven Fleet Capital Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Sell
191,354
-14,188
-7% -$17.7K 0.06% 82
2026
Q1 		$228K Buy
205,542
+70,224
+52% +$98.5K 0.07% 102
2025
Q4 		$263K Buy
+135,318
New +$317K 0.18% 61

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Seven Fleet Capital Management's ENTX Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Entera Bio (ENTX) stake by 6.9% in Q2 2026, selling an estimated $17.7K and leaving 191,354 shares worth $339K. The position accounts for 0.06% of the portfolio, ranked #82.

Seven Fleet Capital Management first reported a position in ENTX in Q4 2025 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Seven Fleet Capital Management held 191,354 shares of Entera Bio worth $339K as of Q2 2026.
  • Seven Fleet Capital Management sold 14,188 Entera Bio shares in Q2 2026, an estimated $17.7K.
  • Entera Bio made up 0.06% of Seven Fleet Capital Management's portfolio in Q2 2026, its #82 holding.
  • Seven Fleet Capital Management first reported a position in Entera Bio in Q4 2025 and has held it in 3 quarters since.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.